Physician profile
Benjamin Resio
NPI 1316325319
$907.38
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $144 · 2023: $220 · 2024: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $231.21 | 2023-2024 | Inspiris Resilia Aortic Valve |
| Davol INC. | $144.33 | 2021 | |
| Merck Sharp & Dohme LLC | $124.93 | 2024 | Keytruda |
| Astrazeneca Pharmaceuticals LP | $117.59 | 2023 | Tagrisso |
| Medtronic, INC. | $105.48 | 2024 | Signia |
| Atricure, INC. | $105.34 | 2024 | |
| Baxter Healthcare | $49.52 | 2024 | Perclot |
| Intuitive Surgical, INC. | $28.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Resio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.